Form D — Vitalis Therapeutics, Inc.
0000929638-25-000820 · filed Feb 19, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $3,004,968
- Reported amount sold
- $1,954,956
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Vitalis Therapeutics, Inc.
- CIK
- 2026886
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 93 4TH AVENUE, #19
NEW YORK, NY 10003 - Phone
- 646-831-7338
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Joseph Habboushe · DirectorNew York, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗